-
EP4376832
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4376832
| EP4376832 - TREATMENT OF HIS HYPORESPONDERS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 03.05.2024 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 03.02.2023 | ||
| Former | unknown Status updated on 24.08.2022 | Most recent event Tooltip | 26.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states NewAmsterdam Pharma B.V. Gooimeer 2-35 1411 DC Naarden / NL | [2024/23] | Inventor(s) | 01 /
KASTELEIN, Johannes Jacob Pieter 1411 DC Naarden / NL | 02 /
DITMARSCH, Marc 1411 DC Naarden / NL | 03 /
DAVIDSON, Michael Harvey 1411 DC Naarden / NL | [2024/23] | Representative(s) | Nederlandsch Octrooibureau P.O. Box 29720 2502 LS The Hague / NL | [2024/23] | Application number, filing date | 22754412.9 | 25.07.2022 | [2024/23] | WO2022EP70780 | Priority number, date | EP20210187721 | 26.07.2021 Original published format: EP 21187721 | [2024/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023006657 | Date: | 02.02.2023 | Language: | EN | [2023/05] | Type: | A1 Application with search report | No.: | EP4376832 | Date: | 05.06.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.02.2023 takes the place of the publication of the European patent application. | [2024/23] | Search report(s) | International search report - published on: | EP | 02.02.2023 | Classification | IPC: | A61K31/40, A61K31/505, A61K31/506, A61P3/06 | [2024/23] | CPC: |
A61P3/06 (EP,IL,KR);
A61K31/40 (EP,IL,KR,US);
A61K31/513 (KR);
A61K31/506 (EP,IL,US);
A61K31/505 (EP,IL,KR,US);
A61P9/10 (IL,KR,US);
A61K2300/00 (KR);
A61P3/04 (KR);
A61P3/10 (KR);
A61P9/12 (KR)
(-)
| C-Set: |
A61K31/40, A61K2300/00 (EP);
A61K31/505, A61K2300/00 (EP);
A61K31/506, A61K2300/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/23] | Extension states | BA | 19.02.2024 | ME | 19.02.2024 | Validation states | KH | 19.02.2024 | MA | 19.02.2024 | MD | 19.02.2024 | TN | 19.02.2024 | Title | German: | BEHANDLUNG VON HIS-HYPRERESPONDERN | [2024/23] | English: | TREATMENT OF HIS HYPORESPONDERS | [2024/23] | French: | TRAITEMENT DES HYPO-RÉPONDEURS AUX HIS | [2024/23] | Entry into regional phase | 19.02.2024 | National basic fee paid | 19.02.2024 | Designation fee(s) paid | 19.02.2024 | Examination fee paid | Examination procedure | 25.05.2023 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 19.02.2024 | Examination requested [2024/23] | 19.02.2024 | Date on which the examining division has become responsible | 03.04.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 25.07.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [YD]WO2016032324 (DEZIMA PHARMA B V [NL]); | by applicant | EP1730152 | EP2007728 | US7872126 | US8084611 | WO2013169797 | WO2016032324 | EP3180314 | US10112904 | US10300059 |